FMA Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FMA Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$211K	Hold	1,680	–	–	0.08%	132
2021 Q2	$227K	Hold	1,680	–	–	0.08%	119
2021 Q1	$228K	Hold	1,680	–	–	0.07%	162
2020 Q4	$236K	Buy	+1,680	New	+$215K	0.08%	161
2018 Q3	–	Sell	-2,099	Closed	-$200K	–	158
2018 Q2	$200K	Buy	+2,099	New	+$193K	0.09%	144
2015 Q2	$61K	Buy	+720	New	+$56K	0.04%	178

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FMA Advisory's XBI Position: Q3 2021 in Review

FMA Advisory held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2021 at 1,680 shares worth $211K. The position accounts for 0.08% of the portfolio, ranked #132.

FMA Advisory first reported a position in XBI in Q2 2015 and has held it in 6 quarters since. The position peaked at $236K in Q4 2020. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

FMA Advisory held 1,680 shares of State Street SPDR S&P Biotech ETF worth $211K as of Q3 2021.
FMA Advisory left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2021.
State Street SPDR S&P Biotech ETF made up 0.08% of FMA Advisory's portfolio in Q3 2021, its #132 holding.
FMA Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 6 quarters since.
FMA Advisory's State Street SPDR S&P Biotech ETF position peaked at $236K in Q4 2020.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.